<DOC>
	<DOCNO>NCT02416973</DOCNO>
	<brief_summary>To demonstrate analgesic effectiveness 2 modality PEMF treatment compare sham treatment patient persistent pain follow lumbar surgery treatment administer twice daily 60 day period .</brief_summary>
	<brief_title>Study PEMF ( Pulsed Electromagnetic Field ) Therapy Treatment Persistent Post-Operative Pain Following Lumbar Surgery</brief_title>
	<detailed_description />
	<criteria>1 . Subject age great equal 22 year . 2 . Subject undergone one two anatomically successful lumbar back surgeries treatment low back pain . 3 . Subject persistent pain low back and/or radiate pain leg ( ) &gt; 3 month &lt; 36 month follow recent surgery . If radiate leg pain occur leg , one leg , bad Average Pain Intensity week prior Screening Visit , select index leg . 4 . Subject receive medication persistent postoperative low back and/or radiate leg pain , include opioid nonopioid analgesic medication , stable analgesic dose regimen ( i.e . medication dosage ) &gt; 30 day prior Screening Visit . 5 . Average Pain Intensity ( calculate mean daily Average Pain Intensity score either back and/or leg ) â‰¥ 3 &lt; 9 measure Numeric Pain Rating Scale ( NPRS ) 10day runin period . 6 . Subject complete minimum 80 % ( 8 10 possible ) electronic Patient Reported Outcome ( ePRO ) assessments 10 day runin period . 7 . Subject able access internet browser home environment . 8 . Subject willing able give write informed consent comply part study protocol . 9 . Female subject must postmenopausal , surgically sterile , abstinent , practicing ( agree practice ) effective method birth control sexually active duration study . ( Effective method birth control include prescription hormonal contraceptive , intrauterine device , doublebarrier method , and/or male partner sterilization ) . 1 . Subject history two lumbar spine surgery . 2 . Subject require additional lumbar surgery surgery type prior Day 75 . 3 . Subject disc fusion level recent surgery . 4 . Subject receive investigational drug device within 30 day 5 halflives drug , whichever longer , prior Screening Visit enrol another clinical trial . 5 . Subject undergone local injection lumbar spine within 30 day prior Screening Visit within 6 week prior Screening Visit long act lidocaine injection product . 6 . Subject use systemic corticosteroid within 2 month Screening Visit . 7 . Subject history uncontrolled medical illness investigator 's judgment place subject unacceptable risk receipt PEMF therapy . 8 . Subject history malignancy within past five year successfully treat nonmetastatic basal cell squamous cell carcinoma skin treatment area and/or localize situ carcinoma cervix . 9 . Subject ongoing painful condition opinion investigator might confound influence safety effectiveness analysis study . 10 . Subject serious psychosocial comorbidity . 11 . Subject history drug alcohol abuse within one year prior screen . 12 . Subject implanted pacemaker , defibrillator , neurostimulator , spinal cord stimulator , bone stimulator , cochlear implant , implanted device implant metal lead ( ) . 13 . Subject consumes average &gt; 100 mg oral Morphine Sulfate equivalent per day 10 day runin period . 14 . Standard deviation around mean average pain intensity score 10 day runin period &gt; 2.0 . 15 . Subject Body Mass Index ( BMI ) &gt; 38 kg/m2 . 16 . Subject currently pregnant plan become pregnant prior Day 75 . 17 . Subject previously treat PROVANT Therapy System . 18 . Subject current litigation regard back pain receiving Worker 's Compensation . 19 . Subject unwilling unable follow study instruction , comply treatment regimen , study visit , ePRO assessment .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>